SE9403833D0 - Analysförfarande och kit - Google Patents

Analysförfarande och kit

Info

Publication number
SE9403833D0
SE9403833D0 SE9403833A SE9403833A SE9403833D0 SE 9403833 D0 SE9403833 D0 SE 9403833D0 SE 9403833 A SE9403833 A SE 9403833A SE 9403833 A SE9403833 A SE 9403833A SE 9403833 D0 SE9403833 D0 SE 9403833D0
Authority
SE
Sweden
Prior art keywords
pct
kit
sec
date
endothelial cells
Prior art date
Application number
SE9403833A
Other languages
English (en)
Swedish (sv)
Inventor
Mats Raanby
Original Assignee
Global Hemostasis Inst Mgr Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Global Hemostasis Inst Mgr Ab filed Critical Global Hemostasis Inst Mgr Ab
Priority to SE9403833A priority Critical patent/SE9403833D0/xx
Publication of SE9403833D0 publication Critical patent/SE9403833D0/xx
Priority to JP8515252A priority patent/JPH10509514A/ja
Priority to PCT/SE1995/001324 priority patent/WO1996014581A1/en
Priority to EP95938102A priority patent/EP0870200A1/en
Priority to US08/817,830 priority patent/US6156530A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE9403833A 1994-11-08 1994-11-08 Analysförfarande och kit SE9403833D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9403833A SE9403833D0 (sv) 1994-11-08 1994-11-08 Analysförfarande och kit
JP8515252A JPH10509514A (ja) 1994-11-08 1995-11-08 止血活性の分析のための方法、試薬およびキット
PCT/SE1995/001324 WO1996014581A1 (en) 1994-11-08 1995-11-08 Method, reagent and kit for analysis of haemostatic activity
EP95938102A EP0870200A1 (en) 1994-11-08 1995-11-08 Method, reagent and kit for analysis of haemostatic activity
US08/817,830 US6156530A (en) 1994-11-08 1995-11-08 Method for analysis of haemostatic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9403833A SE9403833D0 (sv) 1994-11-08 1994-11-08 Analysförfarande och kit

Publications (1)

Publication Number Publication Date
SE9403833D0 true SE9403833D0 (sv) 1994-11-08

Family

ID=20395894

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9403833A SE9403833D0 (sv) 1994-11-08 1994-11-08 Analysförfarande och kit

Country Status (5)

Country Link
US (1) US6156530A (xx)
EP (1) EP0870200A1 (xx)
JP (1) JPH10509514A (xx)
SE (1) SE9403833D0 (xx)
WO (1) WO1996014581A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708591A (en) 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6429017B1 (en) 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US6898532B1 (en) * 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
WO2000046603A1 (en) 1999-02-04 2000-08-10 Akzo Nobel N.V. A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
DE19938520A1 (de) * 1999-08-13 2001-02-22 Vascular Biotech Gmbh Verfahren zur Qualitätskontrolle der Endothelauskleidung nativer Blutgefäße oder im Gewebelabor endothelialisierter, künstlicher oder natürlicher Blutgefäße und Blutgefäßklappen, Herzhöhlen und Herzklappen
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
MXPA05007888A (es) * 2003-01-27 2005-12-15 Harvest Technologies Inc Coagulante autologo y homologo producido a partir de sangre entera anticoagulada.
CA2623142C (en) * 2004-09-22 2016-01-19 The Regents Of The University Of Colorado, A Body Corporate Methods for a global assay of coagulation and fibrinolysis
US7735494B2 (en) 2006-03-03 2010-06-15 Xerosmoke, Llc Tabacco smoking apparatus
CN107250375A (zh) 2014-11-06 2017-10-13 科罗拉多州立大学董事会 在血栓溶解剂存在下使用粘弹性分析鉴定新疾病状态
US11143659B2 (en) 2015-01-27 2021-10-12 Arterez, Inc. Biomarkers of vascular disease
WO2016200765A1 (en) 2015-06-08 2016-12-15 The Regents Of The University Of Colorado, A Body Corporate Time independent viscoelastic analysis parameter for prediction of patient outcome
WO2017205074A1 (en) 2016-05-11 2017-11-30 Chapman Michael P Viscoelastic analysis in patients with disease associated with the cardiovascular system
CA3029905C (en) * 2016-07-12 2021-11-30 EMULATE, Inc. Uses of microfluidic devices comprising additive channels

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097238A (en) * 1977-06-03 1978-06-27 Ashley Sheldon J Method of analyzing blood plasma clotting
US4695956A (en) * 1984-11-01 1987-09-22 Leveen Eric G Apparatus and method of quantifying hemostasis using oscillations from a transducer immersed in the blood sample
US4979959A (en) * 1986-10-17 1990-12-25 Bio-Metric Systems, Inc. Biocompatible coating for solid surfaces
DE3739247C2 (de) * 1987-11-19 1996-11-21 Dade Int Inc Blutungszeitmeßeinrichtung
IE67430B1 (en) * 1988-06-24 1996-04-03 Res Corp Technologies Inc Assay for soluble crosslinked fibrin polymers
SE464135B (sv) * 1989-07-14 1991-03-11 Kabivitrum Ab Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
NO922247L (no) * 1991-07-03 1993-01-04 Hafslund Nycomed As Maalekammerinnsats for bilateral og unilateral blodproppdannelse i delvis stenoserte blodkar, med blandeanordning

Also Published As

Publication number Publication date
WO1996014581A1 (en) 1996-05-17
US6156530A (en) 2000-12-05
EP0870200A1 (en) 1998-10-14
JPH10509514A (ja) 1998-09-14

Similar Documents

Publication Publication Date Title
SE9403833D0 (sv) Analysförfarande och kit
DK1141728T3 (da) Påvisning af nyresygdom og behandling deraf
SE9504046D0 (sv) Method of determining affinity and kinetic properties
DE69832628D1 (de) Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
TR200000565T2 (tr) Biyolojik örneklerdeki analiz bileşenlerinin hızlı analizi için yöntem
DE69333289D1 (de) Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien
DK0947585T3 (da) Forbedret in vitro-fremgangsmåde, kits og reagenser til screening for blodkoagulationsdefekter
EP0277237A4 (en) METHOD AND PROBE FOR SCREENING FOR BACTERIA IN SAMPLES.
DK0486515T3 (da) Fremgangsmåde til bestemmelse af den funktionelle aktivitet af frit protein S eller protein C i en plasmaprøve
DE3788762D1 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
DE69422339D1 (de) Verfahren zur Nachweis von Marijuana in einer Haar Probe
MX9804305A (es) Analisis sanguineo de proporcion del factor v paradeterminar la susceptibilidad a la tromboembolia.
ATE67602T1 (de) Analyseelement zur bestimmung von gerinnungsparametern.
ES2154703T3 (es) Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada.
DK0696642T3 (da) Fremgangsmåde til påvisning af forstyrrelser i protein C/protein S-systemet
NZ332641A (en) method of detecting a lysosomal storage disorder by assaying the level of an enzyme, protein or peptide associated with the disease
ATE239918T1 (de) Verfahren zur im-vitro-analyse von toxischen und allergenen substanzen
EP1757704A3 (en) Methods for detecting mutations associated with hypertrophic cardiomyopathy
DK0791073T3 (da) Analysemetode
ATE242883T1 (de) Verfahren zur bestimmung von blutgerinnungsfaktoren viii und ix
EP1666612A3 (fr) Procédé de détermination de l'activité d'une substance mettant en oeuvre un test fonctionnel in vitro
ES2168509T3 (es) Procedimientos de determinacion in vitro de la bioactividad de la eritropoyetina.
DE60024923D1 (de) Verfahren zur Analyse der funktionellen Aktivierung von Leukocyten, Plättchen und anderen Zellen
ES8500457A1 (es) Un metodo para determinar la capacidad oxidante de un liquido biologico.
DE69520725D1 (de) Verfahren zur Diagnose von Blutgerinnungsstörungen